These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18413557)

  • 1. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea.
    Green SM; Martinez-Rumayor A; Gregory SA; Baggish AL; O'Donoghue ML; Green JA; Lewandrowski KB; Januzzi JL
    Arch Intern Med; 2008 Apr; 168(7):741-8. PubMed ID: 18413557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
    Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
    Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible heart failure.
    Robaei D; Koe L; Bais R; Gould I; Stewart T; Tofler GH
    Ann Clin Biochem; 2011 May; 48(Pt 3):212-7. PubMed ID: 21398433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.
    Baggish AL; Siebert U; Lainchbury JG; Cameron R; Anwaruddin S; Chen A; Krauser DG; Tung R; Brown DF; Richards AM; Januzzi JL
    Am Heart J; 2006 Jan; 151(1):48-54. PubMed ID: 16368291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal pro B-type natriuretic peptide testing for short-term prognosis in breathless older adults.
    Chenevier-Gobeaux C; Allo JC; Arthaud M; Achkar R; Claessens YE; Ekindjian OG; Riou B; Ray P
    Am J Emerg Med; 2008 Jun; 26(5):555-60. PubMed ID: 18534284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
    Januzzi JL; Camargo CA; Anwaruddin S; Baggish AL; Chen AA; Krauser DG; Tung R; Cameron R; Nagurney JT; Chae CU; Lloyd-Jones DM; Brown DF; Foran-Melanson S; Sluss PM; Lee-Lewandrowski E; Lewandrowski KB
    Am J Cardiol; 2005 Apr; 95(8):948-54. PubMed ID: 15820160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
    Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
    Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
    O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
    Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.
    Moe GW; Howlett J; Januzzi JL; Zowall H;
    Circulation; 2007 Jun; 115(24):3103-10. PubMed ID: 17548729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
    Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
    Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients.
    Chenevier-Gobeaux C; Delerme S; Allo JC; Arthaud M; Claessens YE; Ekindjian OG; Riou B; Ray P
    Clin Biochem; 2008 Sep; 41(13):1049-54. PubMed ID: 18573245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.